Evidence map›Paper›PMID 23883518›Full record

SynthesisClinical infectious diseases : an official publication of the Infectious Diseases Society of America2013

Oseltamivir effect on antibiotic-treated lower respiratory tract complications in virologically positive randomized trial participants.

Marc Lipsitch, Miguel A Hernán

Open access · bronzeAbstract readLetterMeta-Analysis
In one paragraph

Synthesis in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Increased Antiviral Treatment Among Hospitalized Children and Adults With Laboratory-Confirmed Influenza, 2010-2015.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2017
    Article
  5. Use of influenza antiviral medications among outpatients at high risk for influenza-associated complications during the 2013-2014 influenza season.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2015
    Article
  6. Article
  7. Use of influenza antiviral agents by ambulatory care clinicians during the 2012-2013 influenza season.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2014
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Marc LipsitchDepartment of Epidemiology.
Miguel A Hernán
Center for Disease Dynamics, Economics & Policy · USHarvard University · US

Funding

Understanding and controlling antibiotic resistanceU54GM088558 · NIGMS · HARVARD SCHOOL OF PUBLIC HEALTH · PI LIPSITCH, MARC · 2009 to 2018
$26.4M
NIGMS NIH HHS U54 GM088558NIGMS NIH HHS U54GM088558
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Anti-Bacterial AgentsAntiviral AgentsBronchopneumoniaHumansIncidenceInfluenza, HumanOseltamivirPneumonia, BacterialRandomized Controlled Trials as TopicAnti-Bacterial AgentsAntiviral AgentsOseltamivir

Identifiers

PMID23883518
PMCPMC3792722
OpenAlexW2117982851

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.